Opiant Pharmaceuticals, Inc. (OPNT), relating to its proposed acquisition by Indivior PLC. Under the terms of the agreement, OPNT shareholders will receive $20.00 in cash plus up to $8.00 per share in CVRs per share they own.
Opiant Pharmaceuticals, Inc. (OPNT), relating to its proposed acquisition by Indivior PLC. Under the terms of the agreement, OPNT shareholders will receive $20.00 in cash plus up to $8.00 per share in CVRs per share they own.